Ipamorelin & CJC-1295: A Research Overview
17 June 2026
Ipamorelin and CJC-1295 are peptides frequently studied together in growth-hormone research. They act on complementary pathways and are often examined as a model system for secretagogue signalling.
What are they?
Ipamorelin is a selective growth-hormone secretagogue that mimics ghrelin at the GHS-receptor. CJC-1295 is a GHRH analogue. Together they are studied for how distinct receptor inputs combine to influence growth-hormone release.
Pathways studied in the literature
- Ghrelin / GHS-receptor signalling (Ipamorelin).
- GHRH-receptor signalling (CJC-1295).
- Pulsatile growth-hormone release in animal models.
- Selectivity — Ipamorelin is studied partly for limited effects on other hormones.
Summary of research findings
Much of the literature centres on how these compounds influence growth-hormone release in preclinical models. They are commonly used as research tools to probe secretagogue mechanisms. As always, interpretation should remain grounded in the specific experimental conditions.
The research described here refers to laboratory and preclinical studies. Defined Labs products are supplied strictly for in vitro research use only.
Related compounds
This guide is for educational purposes and refers to laboratory and preclinical research. All Defined Labs products are supplied strictly for in vitro research use only and are not intended for human or veterinary use, consumption, or any clinical purpose.